Acute Viral Conjunctivitis Author: Stephen Orlin, MD
Module updated - 2008-04-08
Author information and module status
Prevention
Screening
Diagnosis
Consultation for Diagnosis
Hospitalization
Non-drug Therapy
Drug Therapy
Patient Education
Consultation for Management
Follow-up
Tables
Figures
References
Glossary
What's New
Patient Information
Additional Resources
Tools
Frequently Asked Questions
Diagnosis
Is adenoviral conjunctivitis spread by hand-to-eye contact?
Can adenoviral conjunctivitis cause visual loss?
How long can adenovirus survive on inanimate objects?
How contagious is adenovirus?
Besides visual loss, what other morbidity is related to adenoviral conjunctivitis?
Consultation for Diagnosis
Is laboratory testing necessary for acute conjunctivitis?
Non-drug Therapy
Should patients with acute adenoviral conjunctivitis be excused from work?
When are patients with conjunctivitis no longer infectious?
Drug Therapy
Are antibiotics beneficial in adenoviral conjunctivitis?
Should topical steroids be prescribed routinely for viral conjunctivitis?
Patient Education
Can personal hygiene prevent spread of adenoviral conjunctivitis?
Should the patient discard contact lenses after a bout of viral conjunctivitis?
Consultation for Management
Is the conjunctivitis associated with an infectious sexually transmitted disease?
Follow-up
Can acute adenoviral conjunctivitis be associated with chronic visual disturbances?
| Patient Information
Robert Sambursky, MD, editorial consultant, Chief Medical Officer for Rapid Pathogen Screening, Inc.;served as consultant for Rapid Pathogen Screening, Inc.;received an honoraria for Rapid Pathogen Screening, Inc.;serves as consultant for Rapid Pathogen Screening, Inc; owns stock options in Rapid Pathogen Screening, Inc.;served as board member or director for Rapid Pathogen Screening, Inc.;received grants and has grants pending from Rapid Pathogen Screening, Inc.;and has received patents and has patents pending for Rapid Pathogen Screening, Inc. Stephen Orlin, MD has no financial relationships with pharmaceutical companies, biomedical device manufacturers, or health-care related organizations.
Steven E. Weinberger, MD, FACP, Acting Editor, PIER, has stock holdings in Glaxosmithkline and Abbott.

The information included herein should never be used as a substitute for clinical judgment and does not represent an official position of ACP. Because all PIER modules are updated regularly, printed web pages or PDFs may rapidly become obsolete. Therefore, PIER users should compare the date of the last update on the website with any printout to ensure that the information being referred to is the most current available.
PIER is copyrighted (c) 2009 by the American College of Physicians,
190 N. Independence Mall West, Philadelphia, PA 19106-1572, USA.